Pharmaceuticals - Geo Dedicated Fibre

Pharmaceuticals – finding the cure

Companies that regularly invest millions in the development of a single drug have to be certain that that their data is only seen by the right people.

Data network security, therefore, is one of the biggest issues facing players in the pharmaceutical industry.

Data simply must not get into the wrong hands. Developing drugs involves millions of calculations, and so creates huge amounts of valuable information that must be securely stored off-site at a data centre facility. It may then need to be dispersed to lots of different sites.

Like players in the retail and manufacturing sectors, pharmaceutical giants have a complicated supply chain, and a huge data management and data storage requirement.

Within their research and development facilities, these companies have hundreds of high-end workstations in use with scientists and engineers, carrying out data heavy tasks like 3D-modelling and gene splicing, information that must be shared with colleagues all over the world.

With pharmaceuticals consolidating into ever larger companies, each facing an ever more demanding regulatory climate, it is unlikely that data network traffic and storage are going to get any easier to manage. The sort of global web content management platforms they are now deploying are also adding to data overhead, and increasing pressure for a solution like dedicated optical fibre networks.